Tags
congestive heart failure
antitubercular drugs with doubtful efficacy
second line antituberculars
injectable antituberculars
bedaquiline
streptomycin
ethambutol
pyrazinamide
rifampin
isoniazid
antitubercular drugs
conivaptan
tolvaptan
vasopressin receptor antagonists
phosphodiesterase 2 inhibitors
brain natriuretic peptide
nesiritide
milrinone
amrinone
dopamine
sodium nitroprusside
digitoxin
digitalis glycosides
digoxin
symptomatic treatment
bisoprolol
metoprolol
carvediolol
olmesartan
telmisartan
losartán
perindopril
enalapril
captopril
ramipril
beta adrenergic antagonists
beta blockers
arbs
aceis
angiotensin converting enzyme inhibitors
survival benefits
symptomatic benefits
cardiac failure
heart failure
criteria for diagnosis of heart failure
clinical features of heart failure
nyha functional classification of heart failure
right sided heart failure
left sided heart failure
systolic heart failure
diastolic heart failure
See more
Presentations
(4)Tags
congestive heart failure
antitubercular drugs with doubtful efficacy
second line antituberculars
injectable antituberculars
bedaquiline
streptomycin
ethambutol
pyrazinamide
rifampin
isoniazid
antitubercular drugs
conivaptan
tolvaptan
vasopressin receptor antagonists
phosphodiesterase 2 inhibitors
brain natriuretic peptide
nesiritide
milrinone
amrinone
dopamine
sodium nitroprusside
digitoxin
digitalis glycosides
digoxin
symptomatic treatment
bisoprolol
metoprolol
carvediolol
olmesartan
telmisartan
losartán
perindopril
enalapril
captopril
ramipril
beta adrenergic antagonists
beta blockers
arbs
aceis
angiotensin converting enzyme inhibitors
survival benefits
symptomatic benefits
cardiac failure
heart failure
criteria for diagnosis of heart failure
clinical features of heart failure
nyha functional classification of heart failure
right sided heart failure
left sided heart failure
systolic heart failure
diastolic heart failure
See more